
Validation Approach
A risk-based CSV/CSA path from requirements through IQ/OQ/PQ and validated-state control.
ExploreDocumented evidence that a system, process, or method consistently produces a result meeting predetermined specifications and quality attributes.
Validation is the regulatory proof that what you do is what you said you would do — repeatably. It is also one of the fastest-evolving areas of compliance as FDA's CSA shift reshapes how evidence is produced.

Validation is the establishment of documented evidence providing a high degree of assurance that a specific process, computerized system, or analytical method will consistently produce a result meeting its predetermined specifications and quality attributes.
In regulated quality, validation covers three overlapping domains: process validation (manufacturing), method validation (analytical), and computer system validation (CSV) or its modern risk-based variant Computer Software Assurance (CSA).
Inspectors rely on validation records to answer a core question: does this process or system actually produce what you claim? Weak or missing validation is among the most serious compliance failures — FDA Warning Letters frequently cite inadequate validation of computerized systems and manufacturing processes.
The 2022 FDA draft guidance on Computer Software Assurance (CSA) signaled a shift away from script-heavy CSV toward risk-based, fit-for-purpose evidence. Organizations now navigate a transition where legacy CSV programs coexist with modern CSA practice.
CSV (Computer System Validation) emphasizes exhaustive pre-planned scripting. CSA (Computer Software Assurance) emphasizes critical thinking, risk-based evidence depth, and unscripted testing for lower-risk functions. Both satisfy regulation — they differ in evidence strategy.
Validation is referenced across virtually every GxP regulation and quality standard:
A typical validation lifecycle for a computerized system:
Effective validation operations have:
Complere ships with a validation package aligned to CSV/CSA that organizations can adopt as their starting evidence set, then extend for site-specific needs.
Common questions about Validation sourced from regulatory references and inspection patterns.
Validation demonstrates with documented evidence that systems, processes, and equipment consistently perform as intended and remain compliant over time.
Validation establishes a documented foundation for intended use and testing, while verification checks specific outputs comply with those validated controls.
FDA 21 CFR Part 11, EU GMP Annex 11 & 15, MHRA, and WHO expect risk-based lifecycle validation for computerized systems.
Inspectors examine risk-based planning, traceability from requirements to testing, change control, and evidence that periodic review keeps the system in a validated state.
Complere links validation documentation to change control, CAPA, and audit trails so your platform stays validated even as the configuration evolves.
Explore related topics, modules, and compliance resources for a deeper understanding of your quality system.

A risk-based CSV/CSA path from requirements through IQ/OQ/PQ and validated-state control.
Explore
Validation planning, risk assessment, IQ/OQ/PQ protocols, and lifecycle governance for Annex 11.
Explore
How §11.10 and §11.50 controls sit inside everyday approvals and audit trails.
Explore
Where scripted testing earns its cost, where risk-based assurance is enough, and the record each leaves.
Explore
Region is chosen once, at provisioning — what that locks in for latency, service availability and DR.
ExploreWalk through Complere's CSV/CSA-aligned validation package — IQ/OQ/PQ evidence, traceability matrix, and GAMP 5 categorization built into the platform.